Javascript must be enabled to continue!
Striatal Dopaminergic Dysfunction Constrains Motor Invigoration in Parkinson’s Disease
View through CrossRef
Abstract
Bradykinesia is a cardinal motor feature of Parkinson’s disease and is characterised by a reduced ability to generate movements with normal speed and force. Although nigrostriatal dopamine loss is regarded as the primary cause, direct human evidence linking dopaminergic degeneration to striatal dysfunction and impaired motor output and vigour remains limited.
To investigate this relationship, we developed a grip-force paradigm that quantified movement vigour as the ability to rapidly generate force. Fifty-three individuals with Parkinson’s disease, 30 with levodopa-induced dyskinesia and 23 without, and 25 age-matched healthy controls performed the task during 3T functional MRI. Thirty-five patients additionally underwent dopamine transporter PET imaging to assess associations among nigrostriatal dopaminergic integrity, striatal activity and motor performance.
Patients with Parkinson’s disease showed marked reductions in initial movement vigour accompanied by reduced bilateral putaminal activation during force generation. Lower putaminal dopamine transporter binding was associated with both poorer movement vigour and weaker grip-related putaminal activation during functional MRI, establishing a direct link between nigrostriatal degeneration, impaired striatal recruitment and motor slowing. Functional MRI further revealed reduced reward-related responses in the nucleus accumbens. Across participants, stronger reward-related ventral striatal activity was associated with greater movement vigour, suggesting that motivational processes contribute independently to motor performance. Patients with levodopa-induced dyskinesia exhibited more severe putaminal dopaminergic denervation than patients without dyskinesia but showed no additional impairment of movement vigour or striatal task responses.
These findings provide direct
in vivo
evidence that dorsal nigrostriatal dopaminergic degeneration constrains movement vigour in Parkinson’s disease through reduced striatal recruitment during action generation. Impaired reward-related signalling in ventral striatum emerges as an additional, partly independent mechanism influencing motor performance, highlighting distinct motor and motivational contributions to bradykinesia.
Title: Striatal Dopaminergic Dysfunction Constrains Motor Invigoration in Parkinson’s Disease
Description:
Abstract
Bradykinesia is a cardinal motor feature of Parkinson’s disease and is characterised by a reduced ability to generate movements with normal speed and force.
Although nigrostriatal dopamine loss is regarded as the primary cause, direct human evidence linking dopaminergic degeneration to striatal dysfunction and impaired motor output and vigour remains limited.
To investigate this relationship, we developed a grip-force paradigm that quantified movement vigour as the ability to rapidly generate force.
Fifty-three individuals with Parkinson’s disease, 30 with levodopa-induced dyskinesia and 23 without, and 25 age-matched healthy controls performed the task during 3T functional MRI.
Thirty-five patients additionally underwent dopamine transporter PET imaging to assess associations among nigrostriatal dopaminergic integrity, striatal activity and motor performance.
Patients with Parkinson’s disease showed marked reductions in initial movement vigour accompanied by reduced bilateral putaminal activation during force generation.
Lower putaminal dopamine transporter binding was associated with both poorer movement vigour and weaker grip-related putaminal activation during functional MRI, establishing a direct link between nigrostriatal degeneration, impaired striatal recruitment and motor slowing.
Functional MRI further revealed reduced reward-related responses in the nucleus accumbens.
Across participants, stronger reward-related ventral striatal activity was associated with greater movement vigour, suggesting that motivational processes contribute independently to motor performance.
Patients with levodopa-induced dyskinesia exhibited more severe putaminal dopaminergic denervation than patients without dyskinesia but showed no additional impairment of movement vigour or striatal task responses.
These findings provide direct
in vivo
evidence that dorsal nigrostriatal dopaminergic degeneration constrains movement vigour in Parkinson’s disease through reduced striatal recruitment during action generation.
Impaired reward-related signalling in ventral striatum emerges as an additional, partly independent mechanism influencing motor performance, highlighting distinct motor and motivational contributions to bradykinesia.
Related Results
Non-motor asymmetry and dopamine degeneration in Parkinson’s disease
Non-motor asymmetry and dopamine degeneration in Parkinson’s disease
Abstract
Asymmetric dopaminergic degeneration of the striatum is a characteristic feature of Parkinson’s disease, associated with right–left asymmetry in motor funct...
Probing Dopaminergic Modulation via Subthalamic Stimulation: A Preclinical Perspective
Probing Dopaminergic Modulation via Subthalamic Stimulation: A Preclinical Perspective
Introduction: Subthalamic nucleus (STN) deep brain stimulation (DBS) is currently the gold standard symptomatic treatment for patients with levodopa therapy-induced complications i...
Phosphodiesterase 7 Inhibition Induces Dopaminergic Neurogenesis in Hemiparkinsonian Rats
Phosphodiesterase 7 Inhibition Induces Dopaminergic Neurogenesis in Hemiparkinsonian Rats
Abstract
Parkinson's disease is characterized by a loss of dopaminergic neurons in a specific brain region, the ventral midbrai...
Cortico-striatal action control inherent of opponent cognitive-motivational styles
Cortico-striatal action control inherent of opponent cognitive-motivational styles
Abstract
Turning on cue or stopping at a red light requires attending to such cues to select action sequences, or suppress action, in accordance with learned cue-as...
Cardiovascular autonomic dysfunction in Parkinson's disease: associations with disease severity and the modulatory role of dopaminergic therapy
Cardiovascular autonomic dysfunction in Parkinson's disease: associations with disease severity and the modulatory role of dopaminergic therapy
Abstract
Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by both motor and non-motor symptoms, with autonomic dysfunction significa...
Functional autapses form in striatal parvalbumin interneurons but not medium spiny neurons
Functional autapses form in striatal parvalbumin interneurons but not medium spiny neurons
Abstract
Autapses (or self-synapses) selectively form in specific cell types in many brain regions including the neocortex and the hippocampus, w...
New insights underlying the early events of dopaminergic dysfunction in Parkinson’s Disease
New insights underlying the early events of dopaminergic dysfunction in Parkinson’s Disease
Abstract
Alpha melanocyte-stimulating hormone (
α
-MSH) is an autocrine factor released by activated microgli...
Interplay between periodic stimulation and GABAergic inhibition in striatal network oscillations
Interplay between periodic stimulation and GABAergic inhibition in striatal network oscillations
AbstractThe network oscillations are ubiquitous across many brain regions. In the basal ganglia, oscillations are also present at many levels and a wide range of characteristic fre...

